Asia Pacific Dry Eye Syndrome Treatment Market Size & Outlook
Asia Pacific dry eye syndrome treatment market, 2018-2030 (US$M)
Related Markets
Asia Pacific dry eye syndrome treatment market highlights
- The Asia Pacific dry eye syndrome treatment market generated a revenue of USD 830.3 million in 2022.
- The market is expected to grow at a CAGR of 9.5% from 2023 to 2030.
- In terms of segment, evaporative dry eye syndrome was the largest revenue generating type in 2022.
- Evaporative Dry Eye Syndrome is the most lucrative type segment registering the fastest growth during the forecast period.
- Country-wise, India is expected to register the highest CAGR from 2023 to 2030.
Asia Pacific data book summary
| Market revenue in 2022 | USD 830.3 million |
| Market revenue in 2030 | USD 1,715.8 million |
| Growth rate | 9.5% (CAGR from 2022 to 2030) |
| Largest segment | Evaporative dry eye syndrome |
| Fastest growing segment | Evaporative Dry Eye Syndrome |
| Historical data covered | 2018 - 2021 |
| Base year for estimation | 2022 |
| Forecast period covered | 2023 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Evaporative Dry Eye Syndrome, Aqueous Deficient Dry Eye Syndrome |
| Key market players worldwide | Novartis AG ADR, AbbVie Inc, Sun Pharmaceutical Industries, Santen Pharmaceutical Co Ltd, Johnson & Johnson, Otsuka Pharmaceutical, OASIS Medical, Bausch & Lomb Corp, AFT Pharmaceuticals, Oyster Point Pharmaceuticals |
Other key industry trends
- In terms of revenue, Asia Pacific region accounted for 15.0% of the global dry eye syndrome treatment market in 2022.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 1,715.8 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Dry Eye Syndrome Treatment Market Scope
Dry Eye Syndrome Treatment Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Asia Pacific dry eye syndrome treatment market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to dry eye syndrome treatment market will help companies and investors design strategic landscapes.
Evaporative dry eye syndrome was the largest segment with a revenue share of 82.6% in 2022. Horizon Databook has segmented the Asia Pacific dry eye syndrome treatment market based on evaporative dry eye syndrome, aqueous deficient dry eye syndrome covering the revenue growth of each sub-segment from 2018 to 2030.
Asia Pacific consists of a blend of developing and developed economies. Increasing healthcare expenditure in the region is anticipated to fuel market growth. Increasing geriatric population and rising awareness of dry eye syndrome are among the major factors driving the market in this region.
Moreover, the presence of key players, such as Otsuka Pharmaceutical Co., Ltd. and Santen Pharmaceuticals, is expected to contribute to market growth. Furthermore, Indian companies such as Sun Pharmaceutical are expanding their presence in the dry eye syndrome treatment market with new products such as CEQUA.
Furthermore, developed countries in APAC such as Australia are approving the entry of new treatments such as Cationorm emulsion into the market. This product is available in the Pharmaceutical Benefits Scheme from August 2021.
Reasons to subscribe to Asia Pacific dry eye syndrome treatment market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Asia Pacific dry eye syndrome treatment market databook
-
Our clientele includes a mix of dry eye syndrome treatment market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific dry eye syndrome treatment market , including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific dry eye syndrome treatment market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Asia Pacific dry eye syndrome treatment market size, by country, 2018-2030 (US$M)
Asia Pacific Dry Eye Syndrome Treatment Market Outlook Share, 2022 & 2030 (US$M)
Related industry reports
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
